Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, January 1999, p. 140-141, Vol. 6, No. 1
Department of Pathology and Laboratory
Medicine, Summa Health System, Akron, Ohio
443041;
Northeastern Universities
College of Medicine, Rootstown, Ohio 442722; and
Department of Laboratory Medicine, Cleveland Clinic
Foundation, Cleveland, Ohio 441063
Received 5 March 1998/Returned for modification 27 May
1998/Accepted 4 November 1998
Prenatal human immunodeficiency virus (HIV) screening may reduce
vertical HIV transmission. We screened 4,419 prenatal sera and found 38 repeatedly reactive specimens with an HIV-1-HIV-2 enzyme-linked
immunosorbent assay. Western blot analysis confirmed four of these
specimens as positive for HIV-1 antibodies. Screening detects
previously unidentified HIV infections, but false-positive results may
also occur.
1071-412X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Incidence of Human Immunodeficiency Virus Antibody
in a Prenatal Population at a Community Hospital
*
Corresponding author. Mailing address: Dept. of
Pathology and Laboratory Medicine, Summa Health System, 525 E. Market
St., Akron, OH 44304. Phone: (330) 375-3719. Fax: (330) 375-4874. E-mail: alexandt{at}summa-health.org.
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |